欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DK/H/3096/004
药品名称
Cresnisol
活性成分
alanine 21.7 g/l
arginine 14.7 g/l
aspartic acid 4.34 g/l
glutamic acid 7.49 g/l
glycine 10.4 g/l
histidine 8.94 g/l
isoleucine 7.49 g/l
leucine 10.4 g/l
lysine 11.8 g/l
methionine 7.49 g/l
phenylalanine 10.4 g/l
proline 8.94 g/l
serine 5.92 g/l
threonine 7.49 g/l
tryptophan 2.5 g/l
tyrosine 0.39 g/l
valine 9.6 g/l
剂型
Solution for infusion
上市许可持有人
Baxter A/S Tobaksvejen 2 A 2860 Søborg Denmark
参考成员国 - 产品名称
Denmark (DK)
Cresnisol
互认成员国 - 产品名称
Germany (DE)
Flosol 15 % Infusionslösung
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
France (FR)
Spain (ES)
许可日期
2021/01/13
最近更新日期
2023/12/29
药物ATC编码
B05BA01 amino acids
申请类型
TypeLevel1：
Known Active Substance
TypeLevel2：
Additional Strength/Form
TypeLevel3：
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final PL
|
common-pl-cresnisol-wolytes-20210112
Date of last change:2021/10/06
Final SPC
|
common-spc-cresnisol-wolytes-20210112
Date of last change:2021/10/06
Final Labelling
|
common-interpack-cresnisol-n10-20210112
Date of last change:2021/10/06
Final Labelling
|
common-interpack-cresnisol-n24-20210112
Date of last change:2021/10/06
Final Labelling
|
common-interpack-cresnisol-n18-20210112
Date of last change:2021/10/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase